Gary Lee Jones MD , PhD, FAAN
Neurologist, Pharmacologist, MD, PhD, FAAN. President Hamit-Darwin-Freesh (neuroscience research) and HealthForceOne-Neurology (clinical). www.hamit-darwin-freesh.com
Join to View Full Profile
1625 Dammeron Valley Dr EastDammeron Valley, UT 84783
Phone+1 435-429-6472
Dr. Jones is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Gary Jones, based in Dammeron Valley, UT, specializes in Neurology. His extensive education traces back to a B.S. in Chemistry from Northern Arizona University, a PhD in Pharmacology and an MD from the University of Utah, where he also completed an Internal Medicine internship and a Neurology residency. Details about his professional experiences and publications can be found in his curriculum vitae. His published work includes research on the treatment of TIA and Acute Stroke as well as several papers on 1,4-Dihydropyridine structure-activity relationships.
Education & Training
University of Utah HealthResidency, Neurology, 1988 - 1991- University of Utah HealthInternship, Internal Medicine, 1987 - 1988
University of Utah School of MedicineClass of 1987- University of Utah HealthPost-Doctoral Fellowship, 1974 - 1977
University of UtahPh.D., Pharmacology, 1970 - 1974
Certifications & Licensure
UT State Medical License 1988 - 2028
NV State Medical License 1994 - 1997
American Board of Psychiatry and Neurology Neurology
Publications & Presentations
Journal Articles
- 1,4-Dihydropyridine (DHP) Structure-Activity Relationships (SAR)Jones GL, Azzaoui K, FASEB Journal, 1/1/2000
- Predicting the Maximum Electroshock-Induced Seizure Using Quantitative Structure-Activity Relationships of Anti-Convulsant CompoundsAzzaoui K, Jones GL, FASEB Journal, 1/1/2000
- 1,4-Dihydropyridine (DHP) Structure-Activity Relationships (QSAR): Electron Transfer as a Possible Mode of ActionJones GL, Azzaoui K, Epilepsia, 1/1/2000
Books/Book Chapters
Lectures
- Treatment of TIA and Acute Stroke: Should all patients with TIA be admitted?1/27/2009
- 1,4-Dihydropyridine (DHP) Structure-Activity Relationships (SAR).1/1/2000
- Predicting the Maximum Electroshock�Induced Seizure Using Quantitative Structure-Activity Relationships of Anti-Convulsant Compounds.1/1/2000
Grant Support
- See Curriculum VitaeVariousPresent
Committees
- The Master, See Curriculum Vitae
Research History
- See Curriculum Vitae
Professional Memberships
- Fellow
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
